These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 19829033

  • 1. The effect of phosphodiesterase isoenzyme 5 inhibitors on ureteropelvic junction obstruction in rabbits.
    Wang HG, Yan XY, Cai YM, Wang HG, Chen JY.
    Urol Int; 2009; 83(3):316-22. PubMed ID: 19829033
    [Abstract] [Full Text] [Related]

  • 2. Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy.
    Hirschberg K, Radovits T, Loganathan S, Entz L, Beller CJ, Gross ML, Sandner P, Karck M, Szabó G.
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1508-14. PubMed ID: 19464472
    [Abstract] [Full Text] [Related]

  • 3. Effects of the PDE5-inhibitor vardenafil in a mouse stroke model.
    Royl G, Balkaya M, Lehmann S, Lehnardt S, Stohlmann K, Lindauer U, Endres M, Dirnagl U, Meisel A.
    Brain Res; 2009 Apr 10; 1265():148-57. PubMed ID: 19368809
    [Abstract] [Full Text] [Related]

  • 4. Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction.
    Cheon YK, Cho YD, Moon JH, Im HH, Jung Y, Lee JS, Lee MS, Shim CS.
    Gastrointest Endosc; 2009 May 10; 69(6):1111-6. PubMed ID: 19243765
    [Abstract] [Full Text] [Related]

  • 5. Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue.
    Uckert S, Sormes M, Kedia G, Scheller F, Knapp WH, Jonas U, Stief CG.
    Urology; 2008 Mar 10; 71(3):526-30. PubMed ID: 18342202
    [Abstract] [Full Text] [Related]

  • 6. Gender differences in tail-skin flushing induced by nitrates and phosphodiesterase type 5 inhibitors in a climacteric mouse model.
    Sejima H, Tominaga K, Egawa T, Ikeda M, Shibuya K, Kameyama N, Yamauchi A, Shuto H, Kataoka Y.
    Eur J Pharmacol; 2009 Dec 10; 624(1-3):66-70. PubMed ID: 19818343
    [Abstract] [Full Text] [Related]

  • 7. Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease.
    Ferrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF.
    BJU Int; 2006 Mar 10; 97(3):625-33. PubMed ID: 16469038
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dose-dependent effects of a selective phosphodiesterase-5-inhibitor on endothelial dysfunction induced by peroxynitrite in rat aorta.
    Korkmaz S, Radovits T, Barnucz E, Neugebauer P, Arif R, Hirschberg K, Loganathan S, Seidel B, Karck M, Szabó G.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):155-62. PubMed ID: 19482016
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of enalapril on renal resistive index, urine electrolyte levels and TGF-β1 levels of kidney tissues in rats with unilateral partial ureteropelvic junction obstruction.
    Karakus SC, Turkyilmaz Z, Sonmez K, Karabulut R, Sivri B, Ogur T, Yilmaz E, Basaklar AC.
    Eur J Pediatr Surg; 2011 Dec 01; 21(6):356-61. PubMed ID: 22169987
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo effects of vardenafil (a PDE-5 Inhibitor) on corpus cavernosal smooth muscle relaxation in diabetic rabbits.
    Lau DH, Mumtaz FH, Mikhailidis DP, Thompson CS.
    Urol Int; 2009 Dec 01; 82(1):101-7. PubMed ID: 19172107
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P, Parry G, Dark JH, Macgowan GA.
    J Heart Lung Transplant; 2009 Jul 01; 28(7):676-82. PubMed ID: 19560695
    [Abstract] [Full Text] [Related]

  • 16. Conversion of phosphodiesterase-5 (PDE5) catalytic site to higher affinity by PDE5 inhibitors.
    Blount MA, Zoraghi R, Bessay EP, Beasley A, Francis SH, Corbin JD.
    J Pharmacol Exp Ther; 2007 Nov 01; 323(2):730-7. PubMed ID: 17690252
    [Abstract] [Full Text] [Related]

  • 17. Levitra for sphincter of Oddi dysfunction? Are you kidding?
    Affronti J.
    Gastrointest Endosc; 2009 May 01; 69(6):1117-9. PubMed ID: 19410043
    [No Abstract] [Full Text] [Related]

  • 18. Comparative relaxing effects of sildenafil, vardenafil, and tadalafil in human corpus cavernosum: contribution of endogenous nitric oxide release.
    Toque HA, Priviero FB, Teixeira CE, Claudino MA, Baracat JS, Fregonesi A, De Nucci G, Antunes E.
    Urology; 2009 Jul 01; 74(1):216-21. PubMed ID: 19371941
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled, randomized clinical study of the effects of vardenafil on human nasal patency.
    Aydin E, Hizal E, Onay O, Ozgen B, Turhan B, Zaimoglu M, Peskircioglu L, Budakoglu II.
    Am J Rhinol; 2008 Jul 01; 22(3):276-9. PubMed ID: 18588760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.